1st Quarter - Report — MAYO CLINIC for MAYO CLINIC (2015)

Firm

MAYO CLINIC

Client

MAYO CLINIC

Income

—

Expenses

$250,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Railroads RRR

High Speed Rail; Freight Rail Corridor

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Transportation, Dept of (DOT); SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Teaching hospital payments; ACOs; CMMI; Quality Issues; Telemedicine; 340B Program; Generic Drug Pricing.

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Transportation, Dept of (DOT); SENATE

Science/Technology SCI

Telemedicine; Medical Device Technologies; New Diagnostic Tests; Precision Medicine

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Transportation, Dept of (DOT); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Health Issues HCR

Hospital Payments, Physician Payments, Healthcare Grants, Medical Record Privacy, Telemedicine, ICD-10, LDTs

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: HOUSE OF REPRESENTATIVES; Transportation, Dept of (DOT); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

Lab Payments; Lab Oversight; Research Funding

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.